Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01895842
Brief Title: Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

First Submitted : July 5, 2013
First Submitted that Met QC Criteria : July 5, 2013
First Posted : July 11, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : April 11, 2019
Last Update Posted : April 16, 2019